Then we found similar non-significant relationship between GSTT1 deletion and prostate cancer risk among in china, Korea, and Japan, while significant association of null genotype of GSTM1 with increased prostate cancer risk was detected in China and Korea but not in Japan. This evidence concerns the gene GSTM1 and prostate cancer.